EFFECTS OF SIBUTRAMINE ON PLASMA NEUROPEPTIDE Y LEVELS IN PATIENTS WITH OVERWEIGHT AND SIMPLE OBESITY / 解放军医学杂志
Medical Journal of Chinese People's Liberation Army
;
(12)1983.
Article
Dans Chinois
| WPRIM
| ID: wpr-552533
ABSTRACT
The aim of the study was to evaluate the effects of an anti obese agent, sibutramine, on plasma neuropeptide Y(NPY) levels in patients with overweight and simple obesity. 32 patients with overweight and simple obesity were assigned randomly to sibutramine group (group A) or placebo group (group B). Double blind rule was observed in the study. 16 healthy subjects served as control group (group C). Before and after six months of treatment, plasma NPY and serum insulin levels of patients in both groups were measured with radioimmunoassay (RIA). The results showed that fasting plasma NPY levels were higher in obese group than in control group before treatment .No significant difference was found between plasma NPY levels before and after the treatment with sibutramine. The study revealed that patients with overweight and simple obesity had elevated levels of plasma NPY. Sibutramine did not exert any influence on plasma NPY levels in these patients.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Type d'étude:
Essai clinique contrôlé
langue:
Chinois
Texte intégral:
Medical Journal of Chinese People's Liberation Army
Année:
1983
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS